Staszewski, M.; Iwan, M.; Werner, T.; Bajda, M.; Godyń, J.; Latacz, G.; Korga-Plewko, A.; Kubik, J.; Szałaj, N.; Stark, H.;
et al. Guanidines: Synthesis of Novel Histamine H3R Antagonists with Additional Breast Anticancer Activity and Cholinesterases Inhibitory Effect. Pharmaceuticals 2023, 16, 675.
https://doi.org/10.3390/ph16050675
AMA Style
Staszewski M, Iwan M, Werner T, Bajda M, Godyń J, Latacz G, Korga-Plewko A, Kubik J, Szałaj N, Stark H,
et al. Guanidines: Synthesis of Novel Histamine H3R Antagonists with Additional Breast Anticancer Activity and Cholinesterases Inhibitory Effect. Pharmaceuticals. 2023; 16(5):675.
https://doi.org/10.3390/ph16050675
Chicago/Turabian Style
Staszewski, Marek, Magdalena Iwan, Tobias Werner, Marek Bajda, Justyna Godyń, Gniewomir Latacz, Agnieszka Korga-Plewko, Joanna Kubik, Natalia Szałaj, Holger Stark,
and et al. 2023. "Guanidines: Synthesis of Novel Histamine H3R Antagonists with Additional Breast Anticancer Activity and Cholinesterases Inhibitory Effect" Pharmaceuticals 16, no. 5: 675.
https://doi.org/10.3390/ph16050675
APA Style
Staszewski, M., Iwan, M., Werner, T., Bajda, M., Godyń, J., Latacz, G., Korga-Plewko, A., Kubik, J., Szałaj, N., Stark, H., Malawska, B., Więckowska, A., & Walczyński, K.
(2023). Guanidines: Synthesis of Novel Histamine H3R Antagonists with Additional Breast Anticancer Activity and Cholinesterases Inhibitory Effect. Pharmaceuticals, 16(5), 675.
https://doi.org/10.3390/ph16050675